tiprankstipranks
Advertisement
Advertisement

Teva says ‘on track’ to achieve 2027 financial targets

Sees mid-single digit revenue growth (CAGR ’23-’27); Operating income margin 30%; Net debt/adjusted EBITDA 2.0x; Cash to earnings 80%.

Meet Samuel – Your Personal Investing Prophet

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1